Por favor, use este identificador para citar o enlazar este ítem:
https://doi.org/10.3109/00365548.2012.752859
Twittear
Registro completo de metadatos
| Campo DC | Valor | Lengua/Idioma |
|---|---|---|
| dc.contributor.author | Hernández Torres, Alicia | - |
| dc.contributor.author | García Vázquez, Elisa | - |
| dc.contributor.author | Frías Iniesta, José | - |
| dc.contributor.author | Herrero Martínez, José Antonio | - |
| dc.contributor.author | Gómez Gómez, Joaquín | - |
| dc.date.accessioned | 2025-01-31T19:40:56Z | - |
| dc.date.available | 2025-01-31T19:40:56Z | - |
| dc.identifier.citation | Scandinavian Journal of Infectious Diseases, 2012; Early Online: 1–3 | - |
| dc.identifier.issn | Print.: 2374-4235 | - |
| dc.identifier.issn | Electronic.: 2374-4243 | - |
| dc.identifier.uri | http://hdl.handle.net/10201/149908 | - |
| dc.description | © 2012 Informa Healthcar. This document is the published version of a published work that appeared in final form in Scandinavian Journal of Infectious Diseases. . To access the final edited and published work see: https://doi.org/10.3109/00365548.2012.752859 | - |
| dc.description.abstract | Abstract Leishmaniasis is endemic in the Mediterranean region, and the prevalence of latent infection in this area is high. Treatment with tumour necrosis factor (TNF) antagonists represents a major breakthrough in the treatment of several infl ammatory diseases, including psoriasis. Reports describing opportunistic leishmaniasis in European patients treated with TNF- α antagonist drugs are rapidly accumulating. We describe a case of cutaneous leishmaniasis in a patient treated with infl iximab and corticosteroids. | - |
| dc.format | application/pdf | es |
| dc.format.extent | 3 | - |
| dc.language | eng | es |
| dc.publisher | Taylor and Francis Group | - |
| dc.relation | Sin financiación externa a la universidad | es |
| dc.rights | info:eu-repo/semantics/embargoedAccess | es |
| dc.subject | Leishmania | - |
| dc.subject | Cutaneous Leishmaniasis | - |
| dc.subject | Tumour necrosis factor antagonists | - |
| dc.subject | Infliximab | - |
| dc.title | Cutaneous leishmaniasis in a patient receiving infliximab | es |
| dc.type | info:eu-repo/semantics/article | es |
| dc.relation.publisherversion | https://www.tandfonline.com/doi/full/10.3109/00365548.2012.752859 | - |
| dc.embargo.terms | Si | - |
| dc.identifier.doi | https://doi.org/10.3109/00365548.2012.752859 | - |
| dc.contributor.department | Departamento de Medicina | - |
| Aparece en las colecciones: | Artículos | |
Ficheros en este ítem:
| Fichero | Descripción | Tamaño | Formato | |
|---|---|---|---|---|
| Articulo LC.pdf | 127,17 kB | Adobe PDF |  Visualizar/Abrir Solicitar una copia |
Los ítems de Digitum están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.